Highlights From DGX's Q4 Conference Call: Revenues Up 2.7%, EPS Grew 11%; Guides In-line for FY10

January 25, 2010 11:20 AM EST Send to a Friend

Quest Diagnostics Incorporated (NYSE: DGX) reports Q4 EPS of $0.97, 1 cent better than estimates. Revenues were $1.8 billion vs ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Highlights From DGX's Q4 Conference Call: Revenues Up 2.7%, EPS Grew 11%; Guides In-line for FY10

Member Login

Free News Feed